Source:http://linkedlifedata.com/resource/pubmed/id/14575154
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2003-10-24
|
pubmed:abstractText |
The administration of a single bolus of anti-IgM antibody to foetal lambs early in pregnancy produces prolonged B-cell depletion. The present study investigated this depletion by examining the effect, on B-cell development in the ileal Peyer's patches, of varying the timing and dosage of antibody administration and by supplementing anti-IgM with surgical splenectomy. The capacity of a 1 mg bolus of anti-IgM to deplete Peyer's patches of B cells was lost if its administration was deferred until two thirds of the way through pregnancy, but persisted beyond this time if weight-adjusted doses were used. Splenectomy of the foetus performed at an earlier age failed to extend the age at which a 1 mg dose of antibody remained effective. As the concentration of murine immunoglobulin in foetal serum was greatly reduced after 21 days, it is inferred that ongoing suppression of B-cell development is not dependent on the continued presence of murine immunoglobulin. The enduring nature of suppression could be attributable to a limited period during which differentiation of B cells from stem cells normally occurs, although further studies will be needed to investigate this and other possible explanations for the effect of anti-IgM treatment on prenatal B-cell development in sheep.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Anti-Idiotypic,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation...,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin M,
http://linkedlifedata.com/resource/pubmed/chemical/anti-IgM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1740-2522
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
19-26
|
pubmed:dateRevised |
2008-11-20
|
pubmed:meshHeading |
pubmed-meshheading:14575154-Animals,
pubmed-meshheading:14575154-Antibodies, Anti-Idiotypic,
pubmed-meshheading:14575154-Antibodies, Monoclonal,
pubmed-meshheading:14575154-Antigens, Differentiation, B-Lymphocyte,
pubmed-meshheading:14575154-B-Lymphocytes,
pubmed-meshheading:14575154-Dose-Response Relationship, Immunologic,
pubmed-meshheading:14575154-Female,
pubmed-meshheading:14575154-Fetus,
pubmed-meshheading:14575154-Gestational Age,
pubmed-meshheading:14575154-Immunoglobulin M,
pubmed-meshheading:14575154-Immunohistochemistry,
pubmed-meshheading:14575154-Peyer's Patches,
pubmed-meshheading:14575154-Pregnancy,
pubmed-meshheading:14575154-Sheep,
pubmed-meshheading:14575154-Splenectomy
|
pubmed:year |
2003
|
pubmed:articleTitle |
The effect of dosage, gestational age and splenectomy on anti-IgM interception of prenatal B-cell development in sheep.
|
pubmed:affiliation |
John Curtin School of Medical Research, Australian National University, Canberra, ACT 2600, Australia.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|